ATE480241T1 - Transdermale steroidformulierung - Google Patents

Transdermale steroidformulierung

Info

Publication number
ATE480241T1
ATE480241T1 AT05738733T AT05738733T ATE480241T1 AT E480241 T1 ATE480241 T1 AT E480241T1 AT 05738733 T AT05738733 T AT 05738733T AT 05738733 T AT05738733 T AT 05738733T AT E480241 T1 ATE480241 T1 AT E480241T1
Authority
AT
Austria
Prior art keywords
sup
group
weight
steroid formulation
acrylate
Prior art date
Application number
AT05738733T
Other languages
English (en)
Inventor
James Murray
Fumio Kamiyama
Ernst Wuelfert
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Application granted granted Critical
Publication of ATE480241T1 publication Critical patent/ATE480241T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05738733T 2004-04-28 2005-04-28 Transdermale steroidformulierung ATE480241T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409498.3A GB0409498D0 (en) 2004-04-28 2004-04-28 Transdermal steroid formulation
PCT/GB2005/001596 WO2005105104A1 (en) 2004-04-28 2005-04-28 Transdermal steroid formulation

Publications (1)

Publication Number Publication Date
ATE480241T1 true ATE480241T1 (de) 2010-09-15

Family

ID=32408193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05738733T ATE480241T1 (de) 2004-04-28 2005-04-28 Transdermale steroidformulierung

Country Status (25)

Country Link
US (1) US20070231373A1 (de)
EP (1) EP1748779B1 (de)
JP (1) JP4849478B2 (de)
KR (1) KR101139023B1 (de)
CN (1) CN1997375B (de)
AT (1) ATE480241T1 (de)
AU (1) AU2005237285B2 (de)
CA (1) CA2563830C (de)
CY (1) CY1111318T1 (de)
DE (1) DE602005023436D1 (de)
DK (1) DK1748779T3 (de)
ES (1) ES2352202T3 (de)
GB (1) GB0409498D0 (de)
HK (1) HK1096606A1 (de)
HR (1) HRP20100558T1 (de)
IL (1) IL178781A (de)
NO (1) NO337073B1 (de)
NZ (1) NZ550784A (de)
PL (1) PL1748779T3 (de)
PT (1) PT1748779E (de)
RU (1) RU2371183C2 (de)
SI (1) SI1748779T1 (de)
TW (1) TWI354557B (de)
WO (1) WO2005105104A1 (de)
ZA (1) ZA200608878B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0523550D0 (en) * 2005-11-18 2005-12-28 Hunter Fleming Ltd Therapeutic uses of steroidal compounds
CA2670957A1 (en) * 2006-11-30 2008-06-05 Hunter-Fleming Limited Modulation of prostaglandin/cyclooxygenase metabolic pathways

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394429B1 (de) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend gestoden
US4978532A (en) * 1989-08-11 1990-12-18 Pharmedic Co. Dosage form for administration of dehydroepiandrosterone
WO1994026768A1 (en) * 1993-05-18 1994-11-24 Ltt Institute Co., Ltd. Osteogenesis promoter and osteoporosis remedy
US5460820B1 (en) * 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
WO1996036339A2 (en) * 1995-05-15 1996-11-21 Beth Israel Hospital Use of dihydrotestosterone compounds for treating male sexual dysfunction
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
KR100215027B1 (ko) * 1997-01-27 1999-08-16 성재갑 스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형
US20010023261A1 (en) * 1997-01-27 2001-09-20 Lg Chemical Limited. Novel composition for the transdermal administration of drugs
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
GB2363984A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
ES2423899T3 (es) * 2000-08-30 2013-09-25 Unimed Pharmaceuticals, Llc Método para aumentar las concentraciones de testosterona y esteroides relacionados en las mujeres
FR2818148B1 (fr) * 2000-12-15 2005-06-24 Oreal Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
US6510801B2 (en) * 2001-06-01 2003-01-28 Hong Sin Tan Pallet for shrinkwrapped packaging of block rubber
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
WO2004084946A1 (ja) * 2003-03-27 2004-10-07 Cosmed. Co., Ltd. 経皮吸収用粘着剤、経皮吸収用粘着剤組成物及び経皮吸収製剤

Also Published As

Publication number Publication date
NZ550784A (en) 2010-03-26
CA2563830C (en) 2013-01-15
EP1748779A1 (de) 2007-02-07
JP2007534734A (ja) 2007-11-29
CY1111318T1 (el) 2015-08-05
AU2005237285B2 (en) 2010-10-14
CN1997375A (zh) 2007-07-11
IL178781A0 (en) 2007-05-15
NO20065440L (no) 2006-11-27
RU2371183C2 (ru) 2009-10-27
HK1096606A1 (en) 2007-06-08
SI1748779T1 (sl) 2011-01-31
DE602005023436D1 (de) 2010-10-21
WO2005105104A1 (en) 2005-11-10
PT1748779E (pt) 2010-11-02
TWI354557B (en) 2011-12-21
CN1997375B (zh) 2010-09-22
KR20070004995A (ko) 2007-01-09
RU2006141830A (ru) 2008-06-10
JP4849478B2 (ja) 2012-01-11
HRP20100558T1 (hr) 2010-11-30
CA2563830A1 (en) 2005-11-10
PL1748779T3 (pl) 2011-03-31
US20070231373A1 (en) 2007-10-04
EP1748779B1 (de) 2010-09-08
NO337073B1 (no) 2016-01-18
IL178781A (en) 2013-10-31
AU2005237285A1 (en) 2005-11-10
ZA200608878B (en) 2008-07-30
DK1748779T3 (da) 2010-12-13
ES2352202T3 (es) 2011-02-16
GB0409498D0 (en) 2004-06-02
KR101139023B1 (ko) 2012-04-26
TW200538133A (en) 2005-12-01

Similar Documents

Publication Publication Date Title
EP2135908A3 (de) Druckempfindliche Klebstoffzusammensetzung und druckempfindliche Klebefolie zur Anbringung auf einer Metallfläche
TW200724635A (en) Acrylic pressure-sensitive adhesive composition
BRPI0818353A2 (pt) Dispersões aquosas incluindo resina alquídica e polímero de adição tendo segmento(met)acrilato
TW200504169A (en) Pressure-sensitive adhesive for surface-protective film and surface-protective film
EP2135906A3 (de) Druckempfindliche Klebstoffzusammensetzung und ihre Verwendung
EP2135907A3 (de) Druckempfindliche Klebstoffzusammensetzung, druckempfindliche Klebefolie und Herstellungsverfahren dafür
WO2012129362A3 (en) Flame retarding adhesives
EP2492330A3 (de) Entfernbare, wasserdispergierte acrylhaltige druckempfindliche Haftzusammensetzung und druckempfindliches Haftblatt
WO2009052411A3 (en) Methods for treatment of thiol-containing compound deficient conditions
ATE542870T1 (de) Feste druckempfindliche gummihaftzusammensetzung und druckempfindliche haftfolie daraus
ATE437210T1 (de) Haftkleber und klebepflaster
ATE508166T1 (de) Copolymermischung
DE602005008189D1 (de) Haftklebstoffzusammensetzung und hautpflaster
TW200602448A (en) Thermosetting adhesive or pressure-sensitive adhesive composition and thermosetting adhesive or pressure-sensitive adhesive tape or sheet
WO2009120412A3 (en) Adhesive composition having non-tacky microspheres and sheets made therefrom
DE602005020996D1 (de) Kaugummi und gummibasis enthaltend styrol-isopren-styrol-copolymere
EP2324860A3 (de) Druckempfindliche medizinische Klebezusammensetzung
BR112013027484A2 (pt) composição farmacêutica ou nutracêutica com resistência gástrica com resistência contra a influência do etanol
JP2016094616A5 (de)
MX2010007987A (es) Composiciones fotoprotectoras mejoradas.
NO20065440L (no) Transdermal steroidformulering
WO2012136818A3 (en) Cosmetic composition comprising a cucurbic acid compound and a blend of acrylic polymers
ATE355348T1 (de) Medizinische unvernetzte druckempfindliche klebstoffzubereitung, damit versehene medizinische selbstklebefolie und, verfahren zur herstellung von einer medizinischen unvernetzten druckempfindlichen klebstoffzubereitung
MX2015010449A (es) Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos.
JP2012107120A5 (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1748779

Country of ref document: EP